Parabilis Medicines Inc banner

Intrinsic Value

Not Available for PBLS

There is not enough data to reliably calculate the intrinsic value for Parabilis Medicines Inc.

Do our valuations actually work? See backtest results .

Alternatives to PBLS

Fundamental Analysis

What Parabilis Medicines Does

Biotechnology Health Care

Parabilis Medicines Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 145 full-time employees. The company went IPO on 2026-06-10. Parabilis Medicines, Inc., formerly FOG Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The company is built to develop transformative medicines addressing undruggable protein targets driving human disease.

Headquarters
United States of America US
Employees
145
IPO date
Jun 10, 2026
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Parabilis Medicines insiders rarely trade

Insider trading · Last trade on Jul 22, 2026

Sold $0 Nobody sold
Bought $4.7m 1 insider
Trades by date
Open insider trading

Past 12 months

Continue PBLS Research

Decided on Parabilis Medicines? Get an email when PBLS reaches the price you’d buy at. Free with an account.

Back to Top